Female and Neonatal Diagnostic Devices Market Analysis, Size, Trends | United States | 2016-2022 | MedSuite

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Pages: 229
  • Published Date: 12/1/2015
  • Type: MedSuite

The breast imaging segment’s leading growth rate was followed by the obstetrics and gynecology ultrasound segment.  This high rate of growth is due to a strong increase in procedures. The increase in procedures is due to patient demand and parent child bonding ultrasounds. This increase in patient demand has increased sales as OB/GYN doctors look to provide these services in office. The infant warmer and incubator market was the third fastest growing segment due to hospitals opting to purchase warmers and incubators that are convertible, have more features and have more advanced technology. The breast biopsy market is followed closely by the fetal and neonatal monitoring market in terms of growth rate. The overall market value for this segment is driven by the high acuity monitor segment, which carries a high ASP. There are no segments within this market currently declining. In the period immediately before this report, the bone densitometry segment was declining due to massive cuts in reimbursement; however, due to sales involved with body composition testing and an aging population, the segment has managed to reverse this trend and achieve a CAGR of 1%.

This report also includes an analysis of other factors and trends that have positively and negatively impacted the market.

The majority of market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the devices as well as the introduction of new technologies such as digital breast tomosynthesis (DBT) and automated breast ultrasound (ABUS). Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report.

Female and Neonatal Diagnostic Devices Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2022, and Historical Data to 2012
  • Market Drivers & Limiters for Each Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Female and Neonatal Diagnostic Devices Market Share Insights

In 2015, Hologic was the leading competitor in the female and neonatal diagnostic device market. This company has a significant presence in the U.S. breast health market and is known for its commitment to women’s health and innovative products. At one time Hologic held sole possession of the DBT market. Although two additional companies now have FDA approval, Hologic’s early establishment in the market has led to its continued dominance.

GE Healthcare was the second leading competitor in the U.S. market for breast imaging, with a 12.5% share. GE Healthcare was also the second leading competitor in both the digital breast tomosynthesis and digital radiography mammography segments. This company has been producing mammography systems for over 50 years and is focused on developing accurate, efficient and patient-friendly breast imaging products.

Other companies analyzed in this report includes Philips Healthcare, Siemens Healthcare, Mammotome, C.R. Bard, Laborie, Drager Medical, AFGA Healthcare, Atmos Medical BeamMed, Fujifilm Medical, Fukuda Denshi, Hitachi Aloka Medical America Inc, International Biomedical, Konica Minolta Osteometer Meditech, Samsung Madison, SonoCine, Spacelabs Healthcare, Toshiba America Medical Systems, Zonare Medical Systems and various others.

FREE Sample Report

The "US Market for Female and Neonatal Diagnostic Devices" includes analysis on the following companies currently active in this market:
GE Healthcare
Philips Healthcare
Siemens Healthcare
Mammotome (Devicor)
C.R. Bard
Samsung Medison
Dräger Medical
Norland, at Swissray
Others include: AGFA Healthcare, Assured Imaging Mobile Mammography, Atmos Medical BeamMed, Biosound Esaote, BK Medical, CareFusion, Carestream Health, CAS Medical, CMR-Naviscan, Dilon Technologies, Dräger Medical, Fischer-Giotto, Fujifilm Medical, Fujifilm Sonosite, Fukuda Denshi, Gamma Medica Inc., Hitachi Aloka Medical America Inc., Huntleigh Healthcare, Intact Medical, International Biomedical, Konica Minolta, Laborie, Loan Oak Medical Technologies, Machnet, Mindray, Natus Medical, Nihon Kohden, Osteometer Meditech, Planmed OY, Samsung Medison, Scion Medical Technologies, SonoCine, Spacelabs Healthcare, SuperSonic Imagine, Toshiba America Medical Systems, Zonare Medical Systems

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology